Biomarker & Intervention Discovery
PCOS (Polycystic Ovary Syndrome)
Pharmacologically actionable gene targets, therapeutic agents ranked by evidence tier, and active clinical trials.
Spontaneous remissionPCOS is a lifelong endocrine disorder; complete spontaneous resolution rare; some phenotypic improvement with…
Best-intervention remissionWeight loss of 5-10% restores ovulation in 55-90% of anovulatory PCOS women; metformin restores ovulation in 30-50%…
Gap sizeLarge — lifestyle modification and metformin are evidence-based first-line but most patients receive OCPs (treating…
Primary barrierframing/practice
Full remission profile →
Remission & chronicity
Spontaneous remission
PCOS is a lifelong endocrine disorder; complete spontaneous resolution rare; some phenotypic improvement with menopause; fertility returns in 50-70% with ovulation induction; metabolic features persist
Best-intervention remission
Weight loss of 5-10% restores ovulation in 55-90% of anovulatory PCOS women; metformin restores ovulation in 30-50%; letrozole (ovulation induction): 27% live birth rate per cycle (PPCOS II); lifestyle modification: 50-80% improvement in menstrual regularity
Gap size
Large — lifestyle modification and metformin are evidence-based first-line but most patients receive OCPs (treating symptoms only, not the underlying metabolic disorder)
Primary barrier
framing/practice
OCP (oral contraceptive pill) is most commonly prescribed for PCOS, treating symptoms (irregular periods, hirsutism) without addressing the underlying insulin resistance and metabolic risk; OCP does not treat infertility and may worsen insulin sensitivity; the PCOS field has lacked a clear pharmacotherapy standard
Biomarker Targets & Therapeutic Agents
Gene targets queried against DGIdb, Open Targets, ChEMBL, PubMed, and Europe PMC.
Agents ranked: ● Clinical >
● Mechanistic >
● Correlative.
Pipeline results not yet available. Run: python -m biomarker_pipeline.run_for_diseases --skip-llm
Clinical Trials
Recruiting and recently completed trials from ClinicalTrials.gov.
Data retrieved 2026-07-06.
No recent clinical trials found on ClinicalTrials.gov for this condition.
Agents Found By Disease-Level Search
Searched directly from “PCOS (Polycystic Ovary Syndrome)” via ClinicalTrials.gov interventions and Open Targets'
disease→drug data — independent of the 0-gene target panel above.
This surfaces agents whose mechanism doesn't route through a curated gene (combination
therapies, standard-of-care drugs, targets outside the panel).
Not yet run. python -m biomarker_pipeline.run_disease_agent_discovery --disease "..."